发明名称 |
TRANS-EPICUTANEOUS ADMINISTRATION FORM FOR TREATING RESTLESS LEG SYNDROME |
摘要 |
The invention relates to a trans-epicutaneous pharmaceutical composition containing Rotigotin for effective treatment of Restless Leg Syndrome (RLS), especially in the form of a transdermal therapeutic system (TDS) based on acrylate or silicone having a surface of 2.5 - 20 cm<2> and containing 1.125 9.0 mg/cm<2> Rotigotin as an active component against Restless Leg Syndrome, which, according to the International Restless Leg Syndrome Study Group (IRLSSG) Rating Scale, results in an improvement in the conditions of human Restless Leg Syndrome patients in comparison with a placebo treatment of 2 units or more, after administration over a period of time of at least 8 days.
|
申请公布号 |
WO03092677(A1) |
申请公布日期 |
2003.11.13 |
申请号 |
WO2003EP04685 |
申请日期 |
2003.05.05 |
申请人 |
SCHWARZ PHARMA AG |
发明人 |
LAUTERBACH, THOMAS;SCHOLLMAYER, ERWIN |
分类号 |
A61K9/70;A61K31/381;A61K47/04;A61K47/10;A61K47/12;A61K47/14;A61K47/16;A61K47/22;A61K47/32;A61K47/34;A61P25/02;(IPC1-7):A61K31/381;A61K31/045 |
主分类号 |
A61K9/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|